Monday, 22 December 2014

Research Report on Oxygen Therapy Market - Global Industry Segment and Forecast 2019

Oxygen therapy is a medical treatment to administer oxygen in the patient’s body through oxygen therapy devices. Oxygen therapy is performed on the patients who suffers from various respiratory diseases such as chronic obstructive pulmonary disease (COPD). Medical oxygen is contained in a metal cylinder and is allowed to flow through tubes. These tubes can deliver oxygen to lungs via three different modes:
- Nasal cannula: It consists two small plastic tubes that are placed in both the nostrils.
- Face mask: It fits over patient’s mouth andnose.
- Small tube inserted into windpipe through front neck (transtracheal oxygen therapy): Doctor utilizes needle to make small incision to place the tube in windpipe.
Nasal cannula and face mask are advised by physicians when a patient suffers with acute diseases that last for short duration of time. However, transtracheal oxygen therapy is advised to the patients suffering with chronic diseases such as COPD and asthma. Among these, market for nasal cannula accounts for the largest share and is expected to foresee the highest growth rate during the forecast period. This growth is attributed to increasing number of surgeries that require oxygen therapy for shorter duration of time while performing surgeries.
The growth of this market is expected to be significant during the forecast period owing to rising incidences of COPD coupled with increasing awareness amongst population about this medical treatment across the globe. Improvement in healthcare reforms is expected to further propel the growth of this market. Aging population worldwide, also boost the growth of this market.
Some of the major players operating in the oxygen therapy market include 3M, CareFusion, Inc., AstraZeneca, Fisher & Paykel Healthcare Limited, Boehringer Ingelheim GmbH, Chart Industries, Inc., Philips/Respironics, GE Healthcare, MAQUET Medical Systems, Merck & Company, Inc., Smiths Medical, Merck & Company, Inc.and DeVilbiss Healthcare.



No comments:

Post a Comment